Qube Research & Technologies LTD Compugen LTD Transaction History

Qube Research & Technologies LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.68 - $2.52 $42,705 - $64,058	-25,420 Reduced 46.27%	29,516 $49,000
Q1 2024 May 14, 2024	BUY	$1.75 - $2.95 $95,602 - $161,158	54,630 Added 17852.94%	54,936 $141,000
Q4 2023 Feb 13, 2024	BUY	$0.53 - $2.0 $106 - $400	200 Added 188.68%	306 $0
Q3 2023 Nov 13, 2023	BUY	$0.88 - $1.31 $93 - $138	106 New	106 $0
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $41,625 - $88,288	-26,513 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.76 - $4.64 $73,175 - $123,020	26,513 New	26,513 $85,000
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $85,805 - $118,647	-14,794 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.87 - $9.16 $101,634 - $135,513	14,794 New	14,794 $122,000
Q1 2021 May 14, 2021	SELL	$7.67 - $13.77 $102,670 - $184,325	-13,386 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$12.07 - $17.95 $368,678 - $548,282	-30,545 Reduced 69.53%	13,386 $162,000
Q3 2020 Nov 12, 2020	BUY	$14.16 - $19.45 $38,302 - $52,612	2,705 Added 6.56%	43,931 $714,000
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $194,985 - $478,932	27,975 Added 211.12%	41,226 $619,000
Q1 2020 May 15, 2020	BUY	$5.79 - $11.83 $76,723 - $156,759	13,251 New	13,251 $96,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.